CN101850069A - Oral Chinese patent medicament capsule for treating white hair of teenagers - Google Patents
Oral Chinese patent medicament capsule for treating white hair of teenagers Download PDFInfo
- Publication number
- CN101850069A CN101850069A CN200910021828A CN200910021828A CN101850069A CN 101850069 A CN101850069 A CN 101850069A CN 200910021828 A CN200910021828 A CN 200910021828A CN 200910021828 A CN200910021828 A CN 200910021828A CN 101850069 A CN101850069 A CN 101850069A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- fructus
- capsule
- teenagers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a Chinese patent medicament capsule for treating white hair, weak sight, poor memory and hyperactivity of teenagers. The Chinese patent medicament capsule is characterized by comprising the following raw materials in part by weight: 40 to 50 parts of black sesame, 20 to 30 parts of black bean peel, 40 to 50 parts of black non-glutinous rice, 60 to 80 parts of tuber fleeceflower root, 30 to 40 parts of chrysanthemum, 30 to 40 parts of bupleurum, 25 to 30 parts of Chinese dodder seed, 30 to 40 parts of dwarf lilyturf tuber, 25 to 30 parts of gentian, 50 to 60 parts of root of rehmannia, 40 to 50 parts of medlar, 20 to 30 parts of epimedium herb, 15 to 20 parts of root of red-rooted salvia, 25 to 30 parts of anemarrhena asphodeloides bunge, 40 to 50 parts of rehmannia glutinosa, 50 to 60 parts of astragalus, 30 to 40 parts of bitter orange, 30 to 40 parts of common yam rhizome, 40 to 50 parts of fructus corni, 30 to 40 parts of largehead atractylodes rhizome, 25 to 30 parts of radix scutellariae, 30 to 40 parts of Chinese magnoliavine fruit, 40 to 50 parts of thinleaf milkwort root-bark, 40 to 50 parts of glossy privet fruit, 40 to 50 parts of eclipta alba and 20 to 30 parts of liquoric root. The capsule belongs to a pure Chinese medicinal preparation, has safety, reliability and no toxic or side effects, is characterized by short treatment course, high curative effect, low cost and no relapse for treating the white hair of teenagers and has 100 percent of effectiveness ratio and 98 percent of curative ratio; therefore, the capsule is an ideal oral Chinese patent medicament capsule for treating the white hair of teenagers and also has obvious effects of treating hyperactivity, improving memory and recovering sight.
Description
Technical field:
The invention belongs to medical technical field, being specifically related to a kind of is raw material for treating juvenile poliosis oral Chinese patent medicine capsule with Chinese medicine.
Background technology:
Juvenile poliosis is a kind of commonly encountered diseases.At present this disease of treatment does not generally have good method, generally adopts folk prescription among the people and external hair dyeing. and this treatment does not only have effect. and side effect is big on the contrary, and often hair dyeing can cause that scalp allergy may bring out renal carcinoma. lymphatic cancer. symptoms such as leukemia and skin carcinoma.
Summary of the invention:
The objective of the invention is for overcoming disadvantages of background technology, and a kind of short treating period is provided. curative effect height, the oral Chinese patent medicine of the low and treatment juvenile poliosis that do not recur of medical expense.To achieve these goals, the technical solution used in the present invention is: a kind of oral Chinese patent medicine capsule for the treatment of juvenile poliosis is characterized in that raw material composition and the weight portion of making this Chinese medicine capsule are:
Semen Sesami Nigrum 40-50 part Testa sojae atricolor 20-30 part is deceived Semen oryzae sativae 40-50 part Semen Cuscutae 25-30 part
Radix Polygoni Multiflori 60-80 part Flos Chrysanthemi 30-40 part Radix Bupleuri 30-40 part 30-40 Radix Ophiopogonis part
Radix Gentianae 25-30 part Radix Rehmanniae 50-60 part Fructus Lycii 40-50 part negative and positive are 20-30 part suddenly
Radix Salviae Miltiorrhizae 15-20 part Rhizoma Anemarrhenae 25-30 part Radix Rehmanniae Preparata 40-50 part Radix Astragali 50-60 part
Fructus Aurantii 30-40 part Rhizoma Dioscoreae 30-40 part Fructus Corni 40-50 part Rhizoma Atractylodis Macrocephalae 30-40 part
Radix Scutellariae 25-30 part Fructus Schisandrae Chinensis 30-40 part Radix Polygalae 40-50 part Fructus Ligustri Lucidi 40-50 part
Herba Ecliptae 40-50 part Radix Glycyrrhizae 20-30 part
The present invention is complete, and the side has YIN nourishing and the production of body fluid promoting. and mind tranquilizing and the heart calming makes eye bright. nourishing the blood and yin. clearing away heat and cooling blood. soothing the liver kidney tonifying. the inrigorating qi and promoting blood circulation function, thus reached the effect of thorough elimination juvenile poliosis.The present invention compared with prior art has the following advantages: the invention belongs to pure Chinese medicinal preparation. and safe and reliable. have no side effect, the treatment juvenile poliosis is had short treating period. the curative effect height. the low and characteristics that do not recur of expense. effective percentage is 100%. cure rates 98%, be a kind of desirable oral Chinese medicine for the treatment of juvenile poliosis, and to active disease. poor memory. amblyopia power also has obvious effects.
The specific embodiment:
Embodiment 1
Take by weighing each component by following weight portion:
40 parts of 80 parts of Flos Chrysanthemis of 50 parts of Testa sojae atricolors of Semen Sesami Nigrum, 50 parts of Radix Polygoni Multiflori of 30 portions of black Semen oryzae sativaes
60 parts in 30 parts of Radix Rehmanniae of 40 parts of Semen Cuscutae of Radix Bupleuri, 40 portions of Radix Gentianaes, 30 parts of Radix Ophiopogonis
50 parts of negative and positive of Fructus Lycii are 50 parts in 30 parts of Radix Rehmanniaes Preparata of 20 parts of Rhizoma Anemarrhenaes of 30 parts of Radix Salviae Miltiorrhizaes suddenly
40 parts of 50 parts of Rhizoma Atractylodis Macrocephalaes of 40 parts of Fructus Corni of 40 portions of Rhizoma Dioscoreaes of 60 parts of Fructus Aurantiis of the Radix Astragali
50 parts of 50 portions of Herba Ecliptaes of 50 parts of Fructus Ligustri Lucidi of 40 parts of Radix Polygalaes of 30 parts of Fructus Schisandrae Chinensis of Radix Scutellariae
30 parts in Radix Glycyrrhizae
The preparation technology of present embodiment is: take by weighing by above-mentioned weight portion. Semen Sesami Nigrum. and Testa sojae atricolor. black Semen oryzae sativae. Radix Polygoni Multiflori. Flos Chrysanthemi. Radix Bupleuri. Semen Cuscutae. Radix Ophiopogonis. Radix Gentianae. the Radix Rehmanniae. Fructus Lycii. negative and positive are suddenly. Radix Salviae Miltiorrhizae. the Rhizoma Anemarrhenae. Radix Rehmanniae Preparata. the Radix Astragali. Fructus Aurantii. Rhizoma Dioscoreae. Fructus Corni. the Rhizoma Atractylodis Macrocephalae. Radix Scutellariae. Fructus Schisandrae Chinensis. Radix Polygalae. Fructus Ligustri Lucidi. Herba Ecliptae and Radix Glycyrrhizae, clean up respectively, after the dry in the sun oven dry, be placed on a pulverizing, use the 120-200 order, behind the mix homogeneously by system capsular common process and being processed into, be contained in oral each 3-5g in the capsule, every day 6-10g.
Embodiment 2
30 parts of 50 parts of Flos Chrysanthemis of 40 parts of Testa sojae atricolors of Semen Sesami Nigrum, 40 parts of Radix Polygoni Multiflori of 20 portions of black Semen oryzae sativaes
50 parts in 25 parts of Radix Rehmanniae of 30 parts of Semen Cuscutae of Radix Bupleuri, 30 portions of Radix Gentianaes, 25 parts of Radix Ophiopogonis
40 parts of negative and positive of Fructus Lycii are 40 parts in 25 parts of Radix Rehmanniaes Preparata of 15 parts of Rhizoma Anemarrhenaes of 20 parts of Radix Salviae Miltiorrhizaes suddenly
30 parts of 40 parts of Rhizoma Atractylodis Macrocephalaes of 30 parts of Fructus Corni of 30 portions of Rhizoma Dioscoreaes of 50 parts of Fructus Aurantiis of the Radix Astragali
40 parts of 40 portions of Herba Ecliptaes of 30 parts of Fructus Ligustri Lucidi of 30 parts of Radix Polygalaes of 25 parts of Fructus Schisandrae Chinensis of Radix Scutellariae
25 parts in Radix Glycyrrhizae
Embodiment 3
35 parts of 60 parts of Flos Chrysanthemis of 45 parts of Testa sojae atricolors of Semen Sesami Nigrum, 45 parts of Radix Polygoni Multiflori of 25 portions of black Semen oryzae sativaes
55 parts in 27 parts of Radix Rehmanniae of 35 parts of Semen Cuscutae of Radix Bupleuri, 35 portions of Radix Gentianaes, 27 parts of Radix Ophiopogonis
45 parts of negative and positive of Fructus Lycii are 40 parts in 25 parts of Radix Rehmanniaes Preparata of 17 parts of Rhizoma Anemarrhenaes of 25 parts of Radix Salviae Miltiorrhizaes suddenly
35 parts of 45 parts of Rhizoma Atractylodis Macrocephalaes of 35 parts of Fructus Corni of 30 portions of Rhizoma Dioscoreaes of 50 parts of Fructus Aurantiis of the Radix Astragali
45 parts of 45 portions of Herba Ecliptaes of 35 parts of Fructus Ligustri Lucidi of 35 parts of Radix Polygalaes of 28 parts of Fructus Schisandrae Chinensis of Radix Scutellariae
25 parts in Radix Glycyrrhizae
Embodiment 4
33 parts of 56 parts of Flos Chrysanthemis of 43 parts of Testa sojae atricolors of Semen Sesami Nigrum, 43 parts of Radix Polygoni Multiflori of 23 portions of black Semen oryzae sativaes
53 parts in 26 parts of Radix Rehmanniae of 33 parts of Semen Cuscutae of Radix Bupleuri, 33 portions of Radix Gentianaes, 26 parts of Radix Ophiopogonis
43 parts of negative and positive of Fructus Lycii are 43 parts in 26 parts of Radix Rehmanniaes Preparata of 16 parts of Rhizoma Anemarrhenaes of 23 parts of Radix Salviae Miltiorrhizaes suddenly
33 parts of 43 parts of Rhizoma Atractylodis Macrocephalaes of 35 parts of Fructus Corni of 33 portions of Rhizoma Dioscoreaes of 53 parts of Fructus Aurantiis of the Radix Astragali
43 parts of 43 portions of Herba Ecliptaes of 35 parts of Fructus Ligustri Lucidi of 33 parts of Radix Polygalaes of 26 parts of Fructus Schisandrae Chinensis of Radix Scutellariae
23 parts in Radix Glycyrrhizae
Embodiment 5
68 parts of 48 parts of Radix Polygoni Multiflori of 28 portions of black Semen oryzae sativaes of 48 parts of Testa sojae atricolors of Semen Sesami Nigrum
38 parts of 38 parts of Semen Cuscutae of 38 parts of Radix Bupleuri of Flos Chrysanthemi 28 parts of Radix Ophiopogonis
28 parts suddenly of 48 parts of negative and positive of 58 parts of Fructus Lycii of 28 parts of Radix Rehmanniae of Radix Gentianae
58 parts of 48 parts of Radixs Astragali of 28 parts of Radix Rehmanniaes Preparata of 18 parts of Rhizoma Anemarrhenaes of Radix Salviae Miltiorrhizae
38 parts of 48 parts of Rhizoma Atractylodis Macrocephalaes of 38 parts of Fructus Corni of 38 portions of Rhizoma Dioscoreaes of Fructus Aurantii
48 parts of 38 parts of Fructus Ligustri Lucidi of 38 parts of Radix Polygalaes of 28 parts of Fructus Schisandrae Chinensis of Radix Scutellariae
28 parts in 48 portions of Radix Glycyrrhizaes of Herba Ecliptae
Clinical observation case 240 examples of the present invention are the juvenile poliosis patient, wherein treat 120 examples, matched group 120 examples, the treatment group adopts medicine of the present invention. and oral, every day 2 times, each 3-5 gram, 60 days is a course of treatment, matched group adopts hair dyeing, and folk prescription among the people is oral, and 120 days is with the course of treatment.Found that treatment group patient effect is obvious.Effective percentage is 100%, and cure rate is 98%, matched group patient DeGrain, side effect is big on the contrary, and often hair dyeing can cause symptoms such as scalp allergy, and effective percentage is 10%, cure rate is 0, and the present invention tests nontoxic through the juvenile poliosis patient, and the patient is not had irritated reaction.The present invention is through clinical treatment for many years, and is easy to use, and 2 have positive effect to March, and half a year to a year and a half cures, to treating active disease, and poor memory, amblyopia power has obvious effects.
Claims (3)
1. the Chinese medicine capsule of treatment juvenile poliosis, amblyopia power, poor memory and active disease, this medicine is safe and reliable, expense is low, effect is obvious and have no side effect, and it is characterized in that raw material composition and the weight portion of making this Chinese medicine capsule are:
Semen Sesami Nigrum 40-50 part Testa sojae atricolor 20-30 part is deceived Semen oryzae sativae 40-50 part Radix Polygoni Multiflori 60-80 part
Flos Chrysanthemi 30-40 part Radix Bupleuri 30-40 part Semen Cuscutae 25-30 part 30-40 Radix Ophiopogonis part
Radix Gentianae 25-30 part Radix Rehmanniae 50-60 part Fructus Lycii 40-50 part negative and positive are 20-30 part suddenly
Radix Salviae Miltiorrhizae 15-20 part Rhizoma Anemarrhenae 25-30 part Radix Rehmanniae Preparata 40-50 part Radix Astragali 50-60 part
Fructus Aurantii 30-40 part Rhizoma Dioscoreae 30-40 part Fructus Corni 40-50 part Rhizoma Atractylodis Macrocephalae 30-40 part
Radix Scutellariae 25-30 part Fructus Schisandrae Chinensis 30-40 part Radix Polygalae 40-50 part Fructus Ligustri Lucidi 40-50 part
Herba Ecliptae 40-50 part Radix Glycyrrhizae 20-30 part.
2. the characteristics that treatment juvenile poliosis according to claim 1, its feature and usage have short treating period, curative effect height, expense is low and do not recur.
3. treatment juvenile poliosis according to claim 1 is characterized in that the time is short, has no side effect.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910021828A CN101850069A (en) | 2009-04-03 | 2009-04-03 | Oral Chinese patent medicament capsule for treating white hair of teenagers |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910021828A CN101850069A (en) | 2009-04-03 | 2009-04-03 | Oral Chinese patent medicament capsule for treating white hair of teenagers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101850069A true CN101850069A (en) | 2010-10-06 |
Family
ID=42801859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200910021828A Pending CN101850069A (en) | 2009-04-03 | 2009-04-03 | Oral Chinese patent medicament capsule for treating white hair of teenagers |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101850069A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102755049A (en) * | 2012-07-23 | 2012-10-31 | 太仓市伟基生物科技有限公司 | Quilt cover for treating hyperactivity of child |
| CN104208480A (en) * | 2014-09-13 | 2014-12-17 | 吕银兰 | Traditional Chinese medicine for treating premature graying |
| CN104906252A (en) * | 2015-07-03 | 2015-09-16 | 孙淑英 | Traditional Chinese medicine for treating gray hair |
| CN105662039A (en) * | 2016-02-27 | 2016-06-15 | 宁波高新区苗姑养生科技有限公司 | Health-care pillow preventing and treating alopecia areata of children |
-
2009
- 2009-04-03 CN CN200910021828A patent/CN101850069A/en active Pending
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102755049A (en) * | 2012-07-23 | 2012-10-31 | 太仓市伟基生物科技有限公司 | Quilt cover for treating hyperactivity of child |
| CN104208480A (en) * | 2014-09-13 | 2014-12-17 | 吕银兰 | Traditional Chinese medicine for treating premature graying |
| CN104906252A (en) * | 2015-07-03 | 2015-09-16 | 孙淑英 | Traditional Chinese medicine for treating gray hair |
| CN105662039A (en) * | 2016-02-27 | 2016-06-15 | 宁波高新区苗姑养生科技有限公司 | Health-care pillow preventing and treating alopecia areata of children |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100356972C (en) | Chinese medicine for treating amblyopia and myopia | |
| CN1951481A (en) | Medicament for treating cerebral thrombosis | |
| CN100496586C (en) | Medicinal liquor for treating hyperosteogeny and lumbar intervertebral disc protrusion | |
| CN101745034A (en) | Anti-ageing life-prolonging medicine | |
| CN103773662A (en) | Healthcare wine for improving immunity | |
| CN101628080A (en) | Chinese medicinal capsule for tonifying kidney and strengthening yang | |
| CN101167927A (en) | Traditional Chinese medicine formula for treating eye and face spasm | |
| CN104436148A (en) | Traditional Chinese medicine composition for treating hypotension caused by qi-blood deficiency | |
| CN101234172B (en) | Method of preparing Chinese medicine for treating qi-deficiency type metrorrhagia | |
| CN1772161A (en) | Chinese medicine prepn for treating semen abnormality | |
| CN104147551A (en) | Traditional Chinese medicine for treating polycystic ovarian syndrome | |
| CN1765416A (en) | Health caring plaster | |
| CN102872363B (en) | Chinese medicinal oral liquid for treating anemia | |
| CN101850069A (en) | Oral Chinese patent medicament capsule for treating white hair of teenagers | |
| CN104189774A (en) | Traditional Chinese medicine for treating chronic hepatitis B | |
| CN104383461A (en) | Chinese medicinal composition for treating insomnia due to blood stasis | |
| CN101062347A (en) | Chinese traditional medicine formula good for heart and brain | |
| CN1176705C (en) | Chinese medicine for treating hyperosteogeny | |
| CN101167921A (en) | Medicinal composition for treating stomachache and preparation process thereof | |
| CN102813733A (en) | Herb tea capable of resisting cancer, preventing diabetes mellitus and enhancing immunity | |
| CN1240415C (en) | Tablets against allergic purpura | |
| CN1332707C (en) | Formula of Chinese herbal medicine decoction distinguished from males and females and combined with Western medicine for curing hepatitis B | |
| CN103690798B (en) | Medicinal composition for treating teenager leukotrichia and baldness | |
| CN105998645A (en) | Traditional Chinese medicine composition for treating leukotrichia and lipsotrichia | |
| CN102423441A (en) | Double-formula medicine for treating constipation and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20101006 |